The clinical study associated with the SpectraBREAST project has been officially registered on ClinicalTrials.gov under the identifier NCT07111728.
The trial, titled “Spectral and AI-Guided Multimodal Imaging for Real-Time Intraoperative Assessment of Breast Tumor Margins”, is conducted by ICS Maugeri in Pavia, Italy. It is designed to assess the safety and diagnostic performance of an intraoperative imaging system that integrates hyperspectral imaging, Raman spectroscopy, and artificial intelligence to support margin assessment in breast-conserving surgery.
The timely registration of the study and its acceptance by ClinicalTrials.gov represent important milestones in the project. Registration on a publicly accessible international platform enhances the transparency and credibility of the study, supports future dissemination of clinical results, and ensures alignment with international standards for clinical research.
This development also confirms the project’s readiness to advance from system development to clinical testing and strengthens its commitment to generating robust evidence to support the clinical translation of its technologies.
Additional information and updates will be shared through the project’s website and communication channels as the study progresses.
